{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:26:04Z","timestamp":1792805164905,"version":"4.5.0"},"reference-count":34,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Wroclaw Medical University statutory funds","award":["SUBZ.A500.25.019"],"award-info":[{"award-number":["SUBZ.A500.25.019"]}],"id":[{"id":"https:\/\/ror.org\/01qpw1b93","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Primary membranous nephropathy is a leading cause of nephrotic syndrome in adults, characterized by immune complex deposition in the glomerular basement membrane. Predicting proteinuria remission is essential for guiding treatment decisions, optimizing immunosuppressive therapy, and improving renal outcomes. Traditional prognostic markers, such as anti-PLA2R antibody status and baseline proteinuria levels, offer valuable insights into disease progression. However, recent research has identified additional biomarkers that may enhance risk stratification and refine individualized treatment strategies. Serum-based markers, such as uric acid and inflammatory indices, may indicate systemic changes that impact disease progression. Urinary biomarkers, including microhematuria, \u03b11-microglobulin, and CXCL13, have been proposed as potential predictors of disease activity and remission likelihood. Furthermore, histopathological features, such as glomerular basement membrane thickness, tubulointerstitial injury, and acute kidney injury, provide structural correlates that may inform prognosis. This review explores both established and emerging prognostic indicators across various biological domains. Understanding these predictors can aid in developing personalized therapeutic strategies, optimizing disease management, and improving patient outcomes in primary membranous nephropathy.<\/jats:p>","DOI":"10.3390\/jcm14092880","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T20:11:48Z","timestamp":1745352708000},"page":"2880","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prognostic Factors of Proteinuria Remission in Primary Membranous Nephropathy"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1395-7867","authenticated-orcid":false,"given":"Kornelia","family":"Krakowska-Jura","sequence":"first","affiliation":[{"name":"Clinical Department of Nephrology, Transplantation Medicine and Internal Diseases, Institute of Internal Diseases, Wroclaw Medical University, 50-565 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Natalia","family":"Kler","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Wroclaw Medical University, 50-565 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weronika","family":"Wajerowska","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Wroclaw Medical University, 50-565 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4966-9771","authenticated-orcid":false,"given":"Andrzej","family":"Konieczny","sequence":"additional","affiliation":[{"name":"Clinical Department of Nephrology, Transplantation Medicine and Internal Diseases, Institute of Internal Diseases, Wroclaw Medical University, 50-565 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0588-1551","authenticated-orcid":false,"given":"Miros\u0142aw","family":"Banasik","sequence":"additional","affiliation":[{"name":"Clinical Department of Nephrology, Transplantation Medicine and Internal Diseases, Institute of Internal Diseases, Wroclaw Medical University, 50-565 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-pathol-020117-043811","article-title":"Molecular Pathogenesis of Membranous Nephropathy","volume":"15","author":"Ronco","year":"2020","journal-title":"Annu. Rev. Pathol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Gu, Y., Xu, H., and Tang, D. (2021). Mechanisms of Primary Membranous Nephropathy. Biomolecules, 11.","DOI":"10.3390\/biom11040513"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Ronco, P., Plaisier, E., and Debiec, H. (2021). Advances in Membranous Nephropathy. J. Clin. Med., 10.","DOI":"10.3390\/jcm10040607"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/ndt\/gfab316","article-title":"The management of membranous nephropathy-an update","volume":"37","author":"Floege","year":"2022","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1399-0039.1989.tb01741.x","article-title":"A DQA1 allele is strongly associated with idiopathic membranous nephropathy","volume":"34","author":"Vaughan","year":"1989","journal-title":"Tissue Antigens"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrneph.2012.35","article-title":"Pathogenesis of membranous nephropathy: Recent advances and future challenges","volume":"8","author":"Ronco","year":"2012","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/s41467-020-15383-w","article-title":"The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis","volume":"11","author":"Xie","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nrneph.2017.92","article-title":"Treatment of membranous nephropathy: Time for a paradigm shift","volume":"13","author":"Ruggenenti","year":"2017","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Kukuy, O.L., Cohen, R., Gilburd, B., Zeruya, E., Weinstein, T., Agur, T., Dinour, D., Beckerman, P., Volkov, A., and Nissan, J. (2023). The Prognostic Value of Anti-PLA2R Antibodies Levels in Primary Membranous Nephropathy. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24109051"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.ajt.2024.01.036","article-title":"Recurrence of membranous nephropathy after kidney transplantation: A multicenter retrospective cohort study","volume":"24","author":"Hullekes","year":"2024","journal-title":"Am. J. Transpl."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1681\/ASN.2020071082","article-title":"New \u2018Antigens\u2019 in Membranous Nephropathy","volume":"32","author":"Sethi","year":"2021","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2194451","DOI":"10.1080\/0886022X.2023.2194451","article-title":"Acute kidney injury in patients with idiopathic membranous nephropathy: Influencing factors and prognosis","volume":"45","author":"Li","year":"2023","journal-title":"Ren Fail."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2215\/CJN.0000000000000237","article-title":"Anti-PLA2R Antibody Levels and Clinical Risk Factors for Treatment Nonresponse in Membranous Nephropathy","volume":"18","author":"Barbour","year":"2023","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1159\/000527368","article-title":"Diagnosis and Course of Membranous Nephropathy in Adults: Comparison by Age Group","volume":"47","author":"Paulo","year":"2022","journal-title":"Kidney Blood Press. Res."},{"key":"ref_15","first-page":"2615","article-title":"Clinicopathological features and prognosis in patients with idiopathic membranous nephropathy with hypertension","volume":"19","author":"Lu","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000529415","article-title":"Phospholipase A2 Receptor Antibodies and Clinical Prognosis in Patients with Idiopathic Membranous Nephropathy: An Updated Systematic Review and Meta-Analysis","volume":"48","author":"Zhang","year":"2023","journal-title":"Kidney Blood Press. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.kint.2016.09.048","article-title":"Membranous nephropathy: Integrating basic science into improved clinical management","volume":"91","author":"Cattran","year":"2017","journal-title":"Kidney Int."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Jurubi\u021b\u0103, R., Obri\u0219c\u0103, B., Sorohan, B., Achim, C., Micu, G.E., Mircescu, G., and Ismail, G. (2021). Clinical Phenotypes and Predictors of Remission in Primary Membranous Nephropathy. J. Clin. Med., 10.","DOI":"10.3390\/jcm10122624"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2152692","DOI":"10.1080\/0886022X.2022.2152692","article-title":"Clinical features of anemia in membranous nephropathy patients: A Chinese cohort study","volume":"45","author":"Li","year":"2023","journal-title":"Ren. Fail."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Choi, J.Y., Chin, H.J., Lee, H., Bae, E.H., Chang, T.I., Lim, J.H., Jung, H.Y., Cho, J.H., Kim, C.D., and Kim, Y.L. (2020). Idiopathic membranous nephropathy in older patients: Clinical features and outcomes. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0240566"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s11255-019-02254-7","article-title":"Serum uric acid is an independent predictor of renal outcomes in patients with idiopathic membranous nephropathy","volume":"51","author":"Zhang","year":"2019","journal-title":"Int. Urol. Nephrol."},{"key":"ref_22","first-page":"3130","article-title":"A nomogram for the prediction of renal outcomes among patients with idiopathic membranous nephropathy","volume":"20","author":"Zhang","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s11255-023-03803-x","article-title":"Prognostic value of neutrophil-to-lymphocyte ratio on proteinuria remission in patients with idiopathic membranous nephropathy","volume":"56","author":"Gan","year":"2024","journal-title":"Int. Urol. Nephrol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5414\/CN110970","article-title":"The ratio of neutrophils to lymphocytes effectively predicts clinical outcomes in idiopathic membranous nephropathy","volume":"101","author":"Zhao","year":"2024","journal-title":"Clin. Nephrol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2359024","DOI":"10.1080\/0886022X.2024.2359024","article-title":"Fibrinogen-albumin ratio predicts treatment response in phospholipase A2 receptor-associated membranous nephropathy with nephrotic syndrome","volume":"46","author":"Duan","year":"2024","journal-title":"Ren. Fail."},{"key":"ref_26","first-page":"642","article-title":"Systemic immune inflammation index and pan-immune inflammation value as prognostic markers in patients with idiopathic low and moderate risk membranous nephropathy","volume":"27","author":"Kazan","year":"2023","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"He, P., Yu, X., Zha, Y., Liu, J., Wang, H., Huang, C., Sun, S., and He, L. (2021). Microhematuria Enhances the Risks of Relapse and Renal Progression in Primary Membranous Nephropathy. Front. Med., 8.","DOI":"10.3389\/fmed.2021.704830"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"He, P., Zha, Y., Liu, J., Wang, H., and He, L. (2021). Clinical Outcomes of Patients With Primary Membranous Nephropathy and Subnephrotic Proteinuria. Front. Med., 8.","DOI":"10.3389\/fmed.2021.737700"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11255-021-02859-x","article-title":"Nomogram to predict the progression of patients with primary membranous nephropathy and nephrotic syndrome","volume":"54","author":"Liu","year":"2022","journal-title":"Int. Urol. Nephrol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"sfae239","DOI":"10.1093\/ckj\/sfae239","article-title":"Prognostic and therapeutic monitoring value of plasma and urinary cytokine profile in primary membranous nephropathy: The STARMEN trial cohort","volume":"17","author":"Hasegawa","year":"2024","journal-title":"Clin. Kidney J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.ekir.2020.07.018","article-title":"Clinical Use of Complement, Inflammation, and Fibrosis Biomarkers in Autoimmune Glomerulonephritis","volume":"5","author":"Khalili","year":"2020","journal-title":"Kidney Int. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2205951","DOI":"10.1080\/0886022X.2023.2205951","article-title":"Clinical characteristics and prognosis of patients with idiopathic membranous nephropathy with kidney tubulointerstitial damage","volume":"45","author":"Sun","year":"2023","journal-title":"Ren. Fail."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1080\/0886022X.2021.1942913","article-title":"Acute kidney injury in idiopathic membranous nephropathy with nephrotic syndrome","volume":"43","author":"Chen","year":"2021","journal-title":"Ren. Fail."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2179335","DOI":"10.1080\/0886022X.2023.2179335","article-title":"The thickness of glomerular basement membrane predicts complete remission in primary membranous nephropathy","volume":"45","author":"Duan","year":"2023","journal-title":"Ren. Fail."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/9\/2880\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:19:21Z","timestamp":1760030361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/9\/2880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":34,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["jcm14092880"],"URL":"https:\/\/doi.org\/10.3390\/jcm14092880","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]}}}